Market Tracker

09/23 5:16pm ET

Cytokinetics Inc (NASDAQ:CYTK)

8.76
Delayed Data
As of Sep 23
 -0.07 / -0.79%
Today’s Change
6.00
Today|||52-Week Range
13.18
-16.25%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close8.83
Today’s open8.84
Day’s range8.69 - 9.00
Volume279,838
Average volume (3 months)360,875
Market cap$347.8M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)-33.68%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book5.06

Competitors

 Today’s
change
Today’s
% change
AKBAAkebia Therapeutics ...-0.11-1.19%
ARLZAralez Pharmaceutica...+0.21+4.21%
COCPCocrystal Pharma Inc-0.01-0.98%
KPTIKaryopharm Therapeut...-0.36-3.71%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts